Clearfield's FY26 Misses on Revenue but Backlog Surge Sets Up Aggressive FY27 Target

What happened

Clearfield reported fiscal 2026 revenue of $151.9 million, below the $160-170 million guidance range embedded in its prior plan, while gross margin held at 32.0% and diluted EPS from continuing operations came in at just $0.16, far short of the $0.48-0.62 previously targeted. The company ended the year with a sales backlog of $43.3 million, up 75% year over year, and began shipping against a $22 million data center order, providing some evidence of accelerating demand. Management now guides fiscal 2027 revenue to $195-205 million, implying roughly 30% growth, which would require a significant step-up in order conversion. However, the company’s history of lumpy order patterns, reliance on a few distributors, and the slow start to BEAD-funded projects warrant skepticism about the achievability of this target. While the balance sheet remains solid with a large net cash position, the low profitability in FY26 suggests the stock’s valuation may still be ahead of fundamentals until the revenue ramp is proven.

Implication

The shortfall in FY26 EPS underscores that Clearfield's profitability remains fragile and heavily dependent on volume leverage, making the 2027 target difficult to underwrite without more evidence of sustained order flow. The 75% backlog increase and the $22 million data center order are encouraging, as they suggest market demand is finally reaccelerating and diversifying beyond traditional telecom, but they also introduce execution risk in a new vertical. With management guiding to nearly $200 million in revenue for FY27, the stock now appears priced for a scenario that exceeds the prior bull case, leaving limited room for error. Given the company's history of missing guidance due to order timing, the prudent stance is to wait for a couple of quarters of confirmed demand rather than chasing the stock on this announcement. The balance sheet provides downside support, but without a clearer path to meaningful EPS growth, the risk-reward is not compelling at current levels.

Thesis delta

The previous WAIT thesis was predicated on modest growth and waiting for a clearer margin of safety. The FY26 results underperformed on revenue and EPS, but the sharp backlog increase and entry into data centers provide tangible evidence of a demand inflection. This shifts the balance of risks slightly toward the upside if the FY27 ramp materializes, but the aggressive guidance requires validation, so the rating remains WAIT with a heightened focus on execution.